Company Analysis

Clover Health Investments, Corp. (CLOV)

Nasdaq: CLOV · Hospital & Medical Service Plans · Jersey City, NJ · filing with the SEC since 2020
Grade3.5
◀ Past 1.9● Present 3.6▶ Future 5.8
1 est.

Filings

299 filings since 2017 beside 412 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Apr 28, 2026.

Filings a yearinsider forms included
73115668296122157
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 11 times in the last 36 months, the newest Nov 4, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Apr 5, 2024.
Insider forms 412

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 6, 2026 10-Q Quarterly report Sep 30, 2026
Nov 4, 2026 8-K items 2.02, 5.02, 9.01 Results released; Officer or director change · Current report Nov 2, 2026
Oct 9, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Oct 8, 2026
Sep 25, 2026 8-K/A items 5.02, 9.01 Officer or director change · Current report, amended Sep 22, 2026
Sep 24, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Sep 22, 2026
Aug 20, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 7, 2026 10-Q Quarterly report Jun 30, 2026
Aug 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 17, 2026 8-K item 8.01 Other event · Current report Jul 4, 2026
Jun 18, 2026 8-K item 8.01 Other event · Current report Jun 17, 2026
Jun 16, 2026 8-K item 5.02 Officer or director change · Current report Jun 15, 2026
Jun 12, 2026 8-K item 5.07 Shareholder vote · Current report Jun 10, 2026
Jun 10, 2026 8-K item 8.01 Other event · Current report Jun 9, 2026
May 18, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
May 8, 2026 10-Q Quarterly report Mar 31, 2026
May 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 28, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 28, 2026 DEFA14A Extra proxy material
Apr 28, 2026 DEF 14A Proxy statement
Apr 1, 2026 8-K items 5.02, 8.01 Officer or director change; Other event · Current report Mar 30, 2026
Mar 26, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 10, 2026 S-8 Employee stock plan registration
Mar 6, 2026 8-K/A items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report, amended
Mar 6, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Feb 27, 2026 10-K Annual report Dec 31, 2025
Feb 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Jan 14, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Dec 10, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Nov 12, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Nov 7, 2025 10-Q Quarterly report Sep 30, 2025
Nov 4, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Oct 31, 2025 8-K items 5.02, 9.01 Officer or director change · Current report
Oct 9, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 11, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 8, 2025 10-Q Quarterly report Jun 30, 2025
Aug 5, 2025 8-K items 2.02, 9.01 Results released · Current report
Jul 29, 2025 SCHEDULE 13G Large holder notice
Jul 17, 2025 SCHEDULE 13G Large holder notice
Jun 12, 2025 8-K item 5.07 Shareholder vote · Current report Jun 10, 2025
May 14, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
40 of 299 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton CLOV · research, not advice